Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

14 Feb 2022 12:22

Open Orphan launches project collecting viral strains from ill employees

(Sharecast News) - Contract research organisation Open Orphan announced on Monday that its subsidiary hVIVO had launched the 'STRiVE' project, to collect respiratory viral strains suitable for challenge agents from consenting hVIVO employees.

Read more
2 Feb 2022 19:37

TRADING UPDATES: Portfolio updates from Scirocco, Tekcapital, MetalNRG

TRADING UPDATES: Portfolio updates from Scirocco, Tekcapital, MetalNRG

Read more
2 Feb 2022 13:03

Open Orphan reports on world's first Covid-19 characterisation study

(Sharecast News) - Specialist contract research organisation (CRO) Open Orphan announced the results from the world's first Covid-19 characterisation study, which was a partnership between its hVIVO subsidiary, Imperial College London, the Vaccine Taskforce, the Department of Health and Social Care (DHSC), and the Royal Free London NHS Foundation Trust.

Read more
20 Jan 2022 21:13

TRADING UPDATES: GSTechnologies buys crypto exchange; Altus realigns

TRADING UPDATES: GSTechnologies buys crypto exchange; Altus realigns

Read more
21 Dec 2021 15:48

Open Orphan signs £5m human flu study contract

(Sharecast News) - Contract research organisation Open Orphan announced on Tuesday that its subsidiary hVIVO has signed a £5m influenza human challenge study contract with an unnamed biotechnology company, developing an antiviral drug for protection against respiratory viral infections.

Read more
21 Dec 2021 12:23

IN BRIEF: Open Orphan's subsidiary signs GBP5 million contract

IN BRIEF: Open Orphan's subsidiary signs GBP5 million contract

Read more
10 Dec 2021 11:32

Open Orphan signs contract to test antiviral candidate

(Sharecast News) - Specialist contract research organisation Open Orphan announced on Friday that its subsidiary hVIVO has signed a $13.4m contract with an unnamed US-based biotechnology company to test its novel antiviral candidate, using the 'hVIVO Influenza Human Challenge' study model.

Read more
10 Dec 2021 11:28

AIM WINNERS & LOSERS: Omega sinks on UK government repayment demand

AIM WINNERS & LOSERS: Omega sinks on UK government repayment demand

Read more
10 Dec 2021 11:12

Open Orphan shares surge 12% on GBP13 million contract win

Open Orphan shares surge 12% on GBP13 million contract win

Read more
6 Dec 2021 21:32

TRADING UPDATES: Katoro's Blyvoor IPO on hold; Spectra bags new orders

TRADING UPDATES: Katoro's Blyvoor IPO on hold; Spectra bags new orders

Read more
29 Nov 2021 14:33

EXECUTIVE CHANGES: SIMEC and Feedback tap new chief financial officers

EXECUTIVE CHANGES: SIMEC and Feedback tap new chief financial officers

Read more
19 Nov 2021 12:20

TRADING UPDATES: Symphony Environmental's India foray; Panthera drills

TRADING UPDATES: Symphony Environmental's India foray; Panthera drills

Read more
17 Nov 2021 12:09

TRADING UPDATES: Wincanton Primark deal; Mode Global cuts bitcoin fees

TRADING UPDATES: Wincanton Primark deal; Mode Global cuts bitcoin fees

Read more
17 Nov 2021 10:50

Open Orphan subsidiary locks in £5.1m contract with biopharma firm

(Sharecast News) - Contract research organisation Open Orphan revealed on Wednesday that its hVIVO subsidiary had signed a £5.1m contract with a biopharmaceutical company to test its investigational medicinal product.

Read more
15 Nov 2021 12:19

TRADING UPDATES: Billington project delays; Urban Logistics cash raise

TRADING UPDATES: Billington project delays; Urban Logistics cash raise

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.